过去十年中处理房室隔缺损-法洛四联症的早期疗效:先天性心脏病外科医生协会的一项研究。

Connor P Callahan, Madison B Argo, Brian W McCrindle, David J Barron, Anusha Jegatheeswaran, Osami Honjo, Anastasios C Polimenakos, Joseph W Turek, Robert J Dabal, James K Kirklin, William M DeCampli, Pirooz Eghtesady, David M Overman
{"title":"过去十年中处理房室隔缺损-法洛四联症的早期疗效:先天性心脏病外科医生协会的一项研究。","authors":"Connor P Callahan, Madison B Argo, Brian W McCrindle, David J Barron, Anusha Jegatheeswaran, Osami Honjo, Anastasios C Polimenakos, Joseph W Turek, Robert J Dabal, James K Kirklin, William M DeCampli, Pirooz Eghtesady, David M Overman","doi":"10.1177/21501351241293158","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We sought to determine the management and early outcomes of complete atrioventricular septal defect-tetralogy of Fallot (AVSD-TOF) for a contemporary multicenter cohort.</p><p><strong>Methods: </strong>Of 739 participants in the Congenital Heart Surgeons' Society AVSD cohort (January 2012-May 2021), 40 had AVSD-TOF. We first compared survival differences for patients with AVSD-TOF versus those with isolated AVSD using propensity matching. Secondly, for patients with AVSD-TOF, we compared staged (n = 16) versus primary (n = 24) repair by assessing the following: patient characteristics, progression of atrioventricular valve (AVV) regurgitation, and time-related reoperation and survival.</p><p><strong>Results: </strong>Five-year survival was similar between matched AVSD-TOF and isolated AVSD groups (80% vs 81%, <i>P</i> = .9). Compared with primary repair patients, staged patients had smaller pulmonary valve annulus Z-score measured at first presentation (-2.2 vs -2.9, <i>P</i> = .006). All staged patients (12 Blalock-Thomas-Taussig shunts, 3 right-ventricular-outflow-tract stents, 1 ductal stent) survived to complete repair. Freedom from AVSD-related reoperation five years post-AVSD-TOF repair was 57% after staged versus 90% after primary repair (<i>P</i> < .05) and left AVV reoperations were the most frequent reintervention. Survival five years after AVSD-TOF repair was 80% (63% after staged vs 90% after primary repair; <i>P</i> = .08).</p><p><strong>Conclusions: </strong>Patients undergoing AVSD-TOF repair have similar survival compared with matched isolated AVSD patients. Although approximately half of AVSD-TOF patients had initial palliation and all survived to complete repair, staged repair patients had lower survival and a higher reintervention rate compared with primary repair patients. The decision to pursue staged versus primary repair for future babies with AVSD-TOF remains challenging and should be chosen based on individual circumstances.</p>","PeriodicalId":94270,"journal":{"name":"World journal for pediatric & congenital heart surgery","volume":" ","pages":"21501351241293158"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Early Outcomes for Management of Atrioventricular Septal Defect-Tetralogy of Fallot in the Last Decade: A Congenital Heart Surgeons' Society Study.\",\"authors\":\"Connor P Callahan, Madison B Argo, Brian W McCrindle, David J Barron, Anusha Jegatheeswaran, Osami Honjo, Anastasios C Polimenakos, Joseph W Turek, Robert J Dabal, James K Kirklin, William M DeCampli, Pirooz Eghtesady, David M Overman\",\"doi\":\"10.1177/21501351241293158\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>We sought to determine the management and early outcomes of complete atrioventricular septal defect-tetralogy of Fallot (AVSD-TOF) for a contemporary multicenter cohort.</p><p><strong>Methods: </strong>Of 739 participants in the Congenital Heart Surgeons' Society AVSD cohort (January 2012-May 2021), 40 had AVSD-TOF. We first compared survival differences for patients with AVSD-TOF versus those with isolated AVSD using propensity matching. Secondly, for patients with AVSD-TOF, we compared staged (n = 16) versus primary (n = 24) repair by assessing the following: patient characteristics, progression of atrioventricular valve (AVV) regurgitation, and time-related reoperation and survival.</p><p><strong>Results: </strong>Five-year survival was similar between matched AVSD-TOF and isolated AVSD groups (80% vs 81%, <i>P</i> = .9). Compared with primary repair patients, staged patients had smaller pulmonary valve annulus Z-score measured at first presentation (-2.2 vs -2.9, <i>P</i> = .006). All staged patients (12 Blalock-Thomas-Taussig shunts, 3 right-ventricular-outflow-tract stents, 1 ductal stent) survived to complete repair. Freedom from AVSD-related reoperation five years post-AVSD-TOF repair was 57% after staged versus 90% after primary repair (<i>P</i> < .05) and left AVV reoperations were the most frequent reintervention. Survival five years after AVSD-TOF repair was 80% (63% after staged vs 90% after primary repair; <i>P</i> = .08).</p><p><strong>Conclusions: </strong>Patients undergoing AVSD-TOF repair have similar survival compared with matched isolated AVSD patients. Although approximately half of AVSD-TOF patients had initial palliation and all survived to complete repair, staged repair patients had lower survival and a higher reintervention rate compared with primary repair patients. The decision to pursue staged versus primary repair for future babies with AVSD-TOF remains challenging and should be chosen based on individual circumstances.</p>\",\"PeriodicalId\":94270,\"journal\":{\"name\":\"World journal for pediatric & congenital heart surgery\",\"volume\":\" \",\"pages\":\"21501351241293158\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World journal for pediatric & congenital heart surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/21501351241293158\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal for pediatric & congenital heart surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/21501351241293158","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:我们试图确定当代多中心队列中完全性房室间隔缺损-法洛四联症(AVSD-TOF)的管理和早期预后:在先天性心脏病外科医生协会 AVSD 队列(2012 年 1 月至 2021 年 5 月)的 739 名参与者中,有 40 人患有 AVSD-TOF。我们首先使用倾向匹配法比较了AVSD-TOF患者与孤立AVSD患者的生存率差异。其次,对于 AVSD-TOF 患者,我们通过评估患者特征、房室瓣(AVV)反流进展以及与时间相关的再手术和生存率,比较了分期修复(16 例)和初次修复(24 例):结果:匹配的 AVSD-TOF 组和孤立的 AVSD 组的五年生存率相似(80% vs 81%,P = .9)。与初次修复患者相比,分期患者初次就诊时测得的肺动脉瓣环Z-分数较小(-2.2 vs -2.9,P = .006)。所有分期患者(12 例 Blalock-Thomas-Taussig 分流、3 例右室流出道支架、1 例导管支架)均存活至完全修复。AVSD-TOF修复术后五年内,分期手术与AVSD相关再手术的成功率分别为57%和90%(P P = .08):结论:与匹配的孤立 AVSD 患者相比,接受 AVSD-TOF 修复术的患者存活率相似。结论:与匹配的孤立性 AVSD 患者相比,接受 AVSD-TOF 修复术的患者存活率相似。虽然约有一半的 AVSD-TOF 患者最初病情得到缓解,并且所有患者都存活到了完全修复,但与初次修复患者相比,分期修复患者的存活率较低,再次干预率较高。对于未来的 AVSD-TOF 婴儿来说,决定进行分期修复还是初次修复仍具有挑战性,应根据个人情况进行选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Early Outcomes for Management of Atrioventricular Septal Defect-Tetralogy of Fallot in the Last Decade: A Congenital Heart Surgeons' Society Study.

Background: We sought to determine the management and early outcomes of complete atrioventricular septal defect-tetralogy of Fallot (AVSD-TOF) for a contemporary multicenter cohort.

Methods: Of 739 participants in the Congenital Heart Surgeons' Society AVSD cohort (January 2012-May 2021), 40 had AVSD-TOF. We first compared survival differences for patients with AVSD-TOF versus those with isolated AVSD using propensity matching. Secondly, for patients with AVSD-TOF, we compared staged (n = 16) versus primary (n = 24) repair by assessing the following: patient characteristics, progression of atrioventricular valve (AVV) regurgitation, and time-related reoperation and survival.

Results: Five-year survival was similar between matched AVSD-TOF and isolated AVSD groups (80% vs 81%, P = .9). Compared with primary repair patients, staged patients had smaller pulmonary valve annulus Z-score measured at first presentation (-2.2 vs -2.9, P = .006). All staged patients (12 Blalock-Thomas-Taussig shunts, 3 right-ventricular-outflow-tract stents, 1 ductal stent) survived to complete repair. Freedom from AVSD-related reoperation five years post-AVSD-TOF repair was 57% after staged versus 90% after primary repair (P < .05) and left AVV reoperations were the most frequent reintervention. Survival five years after AVSD-TOF repair was 80% (63% after staged vs 90% after primary repair; P = .08).

Conclusions: Patients undergoing AVSD-TOF repair have similar survival compared with matched isolated AVSD patients. Although approximately half of AVSD-TOF patients had initial palliation and all survived to complete repair, staged repair patients had lower survival and a higher reintervention rate compared with primary repair patients. The decision to pursue staged versus primary repair for future babies with AVSD-TOF remains challenging and should be chosen based on individual circumstances.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Contemporary Practice of Native Coarctation in Children Greater Than One Year of Age: A Society of Thoracic Surgeons Analysis. Evaluating Diaphragmatic Paralysis After Pediatric Cardiac Surgery and the Role of Plication in Outcome Improvement: Insights From a Single-Center Experience. Long-Term Coronary Artery Complications Following the Arterial Switch Operation for Transposition of the Great Arteries-A Scoping Review. Neoaortic Dilation and Polyvalvar Dysfunction: The Coexistence of Marfan Syndrome with Hypoplastic Left Heart Syndrome. Pulmonary Atresia and Ventricular Septal Defect: Definitions, Nomenclature, and Classification.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1